NewsBTC
No Result
View All Result
  • Cryptocurrency News
    • Bitcoin News (BTC)
    • Ethereum News (ETH)
    • Ripple News (XRP)
    • Shiba Inu News (SHIB)
    • Cardano News (ADA)
    • Dogecoin News (DOGE)
    • Solana News (SOL)
    • Litecoin News (LTC)
    • Avalanche News (AVAX)
    • Polygon News (MATIC)
  • Crypto Prices
    • Binance Coin (BNB) Price
    • Bitcoin (BTC) Price
    • Cardano (ADA) Price
    • Chainlink (LINK) Price
    • Dogecoin (DOGE) Price
    • Ethereum (ETH) Price
    • Litecoin (LTC) Price
    • Polkadot (DOT) Price
  • Crypto Resources & Directory
  • All Crypto
  • Play GamesTry
  • CasinosTry
Breaking News: Coinbase Confirms DOJ Investigation Following Major Security Incident
  • Cryptocurrency News
    • Bitcoin News (BTC)
    • Ethereum News (ETH)
    • Ripple News (XRP)
    • Shiba Inu News (SHIB)
    • Cardano News (ADA)
    • Dogecoin News (DOGE)
    • Solana News (SOL)
    • Litecoin News (LTC)
    • Avalanche News (AVAX)
    • Polygon News (MATIC)
  • Crypto Prices
    • Binance Coin (BNB) Price
    • Bitcoin (BTC) Price
    • Cardano (ADA) Price
    • Chainlink (LINK) Price
    • Dogecoin (DOGE) Price
    • Ethereum (ETH) Price
    • Litecoin (LTC) Price
    • Polkadot (DOT) Price
  • Crypto Resources & Directory
  • All Crypto
  • Play GamesTry
  • CasinosTry
Bitcoin News
No Result
View All Result
Breaking News: Coinbase Confirms DOJ Investigation Following Major Security Incident

Curaizon Using Big Data to Revolutionize the Pharmaceutical Industry

NewsBTC
NewsBTC
1 year ago
3 mins read
curaizon

Reason to trust

Strict editorial policy that focuses on accuracy, relevance, and impartiality
Created by industry experts and meticulously reviewed
The highest standards in reporting and publishing
How Our News is Made

Strict editorial policy that focuses on accuracy, relevance, and impartiality

Ad discliamer

Morbi pretium leo et nisl aliquam mollis. Quisque arcu lorem, ultricies quis pellentesque nec, ullamcorper eu odio.

The cost of some of the much-needed medication is often a big concern for national health services who are at times reluctant to pay the high prices charged for them. This means that some critically ill patients are given less effective medications that partly treat illness while causing numerous side effects – it is logical to suggest that this can lead to increased non-adherence. From a pharmaceutical company standpoint, high drug prices stem from the investments made in research and development (R&D) to develop new, more effective treatments for various diseases.

According to a recent report by the Tufts Center for the Study of Drug Development, the cost of developing a prescription drug that secures regulatory approval can reach an estimated USD 2.6 billion. A big reason for such a high cost of developing new drugs is the low levels of drug adherence seen presently as well as the related lack of data to inform of the reasons why. In fact, many pharmaceutical companies have seen their profits evaporate as a result. Recent reports estimate more than USD 630 billion in revenue is lost annually as a result of patient non-adherence, and the amount is increasing by 13 percent each year.

The disparity in accurate information often affects the reliability of research on the impact of medications leading to long and exhaustive testing processes. Another sticking point is the restricted access to relevant pieces of patient data for new drug development with factors including data protection, competition, and non-standardized data. Curaizon, a pioneer of medical adherence technologies, is leveraging its blockchain-based technologies to provide the standardized, reliable and real-time big data needed by pharmaceutical companies, medical researchers, and healthcare providers.

According to recent research by the McKinsey Global Institute, standardization of data analytics in healthcare could cut costs by 30%. Until now, pharmaceutical companies have endured high R&D expenditures, burdened by the lack of sufficient data due to limited drug trials, and by issues of the quality of the data present due to the varying research methods used in trials. In addition, competition between different companies has stymied research efforts, while access to certain data may be blocked either by healthcare providers or legislation. Effective May 25, 2018, the European-wide General Data Protection Regulation stipulates that all EU citizens are entitled to know what data have been stored on them and to demand deletion of the data. Compliance with the rules is causing havoc in national health services and complicating access issues for pharmaceutical companies and medical researchers.

Here is where Curaizon comes in. Its CuraData solution merges its patient adherence data with machine learning and AI technologies to develop unique, standardized and anonymized datasets that medical researchers and pharmaceutical companies can easily use. Through its data analytics tools, Curaizon aims to improve the quality and availability of real-time information. Its platform will generate datasets on adherence based on anonymized big data using its technologies to facilitate end-to-end data integration, collaboration between different players in the healthcare sector, predictive modeling of the efficiency of different drugs to enhance clinical trial efficiency. Its adherence technology will also help improve understanding of the efficacy of drugs, something that is hard to achieve when adherence is estimated at only 50%.

The company’s adherence technology was created for the purpose of increasing drug adherence levels, reducing waste and facilitating research for new, more effective medications. The Curaizon ecosystem consists of three key components: CuraServe™, CuraView™, and CuraData™. CuraServe issues non-intrusive reminders to patients so that they take medication on time, while CuraView integrates with national health service systems. Using these technologies, Curaizon captures on average four data points for each patient every day. Unique demographic and adherence data on patients is collected and anonymized through CuraServe, stored and analyzed in CuraData. The data collected by Curaizon’s real-time adherence technologies can be merged with healthcare provider patient data to create even better and detailed datasets to further assist medicine research and development.

With the use of blockchain, the security, transparency, and immutability of medical records can be ensured as access is restricted by the respective rules and storing points.

As both patients and health services use Curaizon’s technologies, it creates opportunities to enhance the adherence data functionality and utility. In turn, data scientists, academics and researchers from pharmaceutical companies can overlay their own data with within CuraData to generate unique insights and further develop the ecosystem.

This indirect collaboration and information sharing from all parties will help reduce costs of medical research. For instance, researchers will gain valuable insights into the shortcomings of existing treatments from patient feedback and real-time information on non-adherence as well as understand any complications that could be linked to a specific drug or form of treatment.

By providing relevant real-time data, Curaizon will help pharmaceutical companies reduce their R&D costs, thereby bringing to market better quality medications quicker and more efficiently. In turn, this will lower the prices paid by patients and healthcare providers.

 

Tweet123Share196ShareSend
NewsBTC
NewsBTC

NewsBTC

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Disclaimer: The information found on NewsBTC is for educational purposes only. It does not represent the opinions of NewsBTC on whether to buy, sell or hold any investments and naturally investing carries risks. You are advised to conduct your own research before making any investment decisions. Use information provided on this website entirely at your own risk.

Related News

Bitcoin

Bitcoin Finds Support Above 50-Day SMA, But Next Direction Remains Uncertain

Bitcoin is holding steady above its 50-day Simple Moving Average (SMA), showing signs of underlying strength despite a lack of...

Godspower Owie 3 hours ago
bhutan crypto payments

Το Μπουτάν υιοθετεί τις κρυπτοπληρωμες παρά τα προβλήματα συνδεσιμότητας

Μέσω της συνεργασίας της Binance Pay με την DK Bank, οι ντόπιοι και οι τουρίστες μπορούν πλέον να κάνουν κρυπτοπληρωμες...

Ανθή Ντόνκοβα 4 hours ago
Ethereum

The ‘MicroStrategy’ Of Ethereum Emerges: Tom Lee And Joe Lubin Raise $675M To Stack ETH

The ‘MicroStrategy’ of Ethereum has emerged, with Fundstrat’s Tom Lee and Joe Lubin making moves to advance their respective ETH...

Scott Matherson 5 hours ago
Load More

Reason to trust

Strict editorial policy that focuses on accuracy, relevance, and impartiality
Created by industry experts and meticulously reviewed
The highest standards in reporting and publishing
How Our News is Made

Strict editorial policy that focuses on accuracy, relevance, and impartiality

Ad discliamer

Morbi pretium leo et nisl aliquam mollis. Quisque arcu lorem, ultricies quis pellentesque nec, ullamcorper eu odio.

Related News

crypto ETF's snorter

Токен Snorter достиг $1,45 млн на ICO: помощь дегенам безошибочно ловить следующий 100-кратный рост

lisachaikina 7 minutes ago
Tron DeFi Activity Expands: SunSwap Hits $3B+ Monthly Swaps In 2025

Tron DeFi Activity Expands: SunSwap Hits $3B+ Monthly Swaps In 2025

Sebastian Villafuerte 49 minutes ago

25 Million Funtokens Burned! – How Does The Community React?

NewsBTC 3 hours ago

Premium Sponsors

Press Releases

  • Szukasz najlepszych kryptowalut do zakupu w 2025 roku

    Szukasz najlepszych kryptowalut do zakupu w 2025 roku? Oto...

    8 minutes ago
  • Best Crypto Payment Gateway for Trading in 2025

    3 hours ago
  • 仮想通貨プレセールで1.45百万ドル調達-人為的ミスを排除し次の100倍を目指す新鋭トークン

    ...

    7 hours ago
  • 仮想通貨おすすめ|2025年に注目のポートフォリオ向け有望銘柄4選とは?

    ...

    7 hours ago
  • 「壮大で美しい法案」成立も暗号資産税制救済なし、新しい仮想通貨が未来を切り開く

    ...

    7 hours ago

Newsletter

Be the first to get the latest important crypto news & events to your inbox.

  • This field is for validation purposes and should be left unchanged.

About Us

NewsBTC is a cryptocurrency news service that covers bitcoin news today, technical analysis & forecasts for bitcoin price and other altcoins. Here at NewsBTC, we are dedicated to enlightening everyone about bitcoin and other cryptocurrencies.

We cover BTC news related to bitcoin exchanges, bitcoin mining and price forecasts for various cryptocurrencies.

Disclaimer: The information found on NewsBTC is for educational purposes only. It does not represent the opinions of NewsBTC on whether to buy, sell or hold any investments and naturally investing carries risks. You are advised to conduct your own research before making any investment decisions. Use information provided on this website entirely at your own risk.

Company

  • About Us
  • Advertising
  • Contact Us
  • Privacy Center

Social

© 2025 NewsBTC. All Rights Reserved.

  • Cryptocurrency News
    • Bitcoin News (BTC)
    • Ethereum News (ETH)
    • Ripple News (XRP)
    • Shiba Inu News (SHIB)
    • Cardano News (ADA)
    • Dogecoin News (DOGE)
    • Solana News (SOL)
    • Litecoin News (LTC)
    • Avalanche News (AVAX)
    • Polygon News (MATIC)
  • Crypto Prices
    • Binance Coin (BNB) Price
    • Bitcoin (BTC) Price
    • Cardano (ADA) Price
    • Chainlink (LINK) Price
    • Dogecoin (DOGE) Price
    • Ethereum (ETH) Price
    • Litecoin (LTC) Price
    • Polkadot (DOT) Price
  • Crypto Resources & Directory
  • All Crypto
  • Play Games
  • Casinos
Advertise

© 2025 NewsBTC. All Rights Reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Center or Cookie Policy.